Anti-Staphylococcus Epidermidis Lipoteichoic Acid Recombinant Antibody
- 
									
产品编号
YR1165
 - 
									
别名
科研级 Pagibaximab ( 帕昔单抗 ), Anti-Lipoteichoic Acid Recombinant Antibody, Research Grade Pagibaximab
 - 
									
规格
- 1mg
 - 5mg
 
 
| Catalog Number | YR1165 | 
| Alias | 科研级 Pagibaximab ( 帕昔单抗 ), Anti-Lipoteichoic Acid Recombinant Antibody, Research Grade Pagibaximab | 
| Size | 1mg, 5mg | 
| Molecular Name | Pagibaximab | 
| CAS Number | 595566-61-3 | 
| Target | Lipoteichoic Acid[Staphylococcus epidermidis] | 
| Antibody Isotype | IgG1 Kappa | 
| Clonity | Monoclonal | 
| Concentration | 1mg/ml | 
| Purity | >95% as determined by SDS-PAGE | 
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. | 
| Formulation | PBS, pH7.5 | 
| Shipping Condition | Shipped on ice packs. | 
| Background | Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of March 2010, it is undergoing Phase II/III clinical trials. | 
| Application | FuncS, IF, Neut, ELISA, FCM, IP | 
| Remarks | This product is for research use only. | 
							
							
							
							
						
								0